Our findings are crucial for the development of novel therapeutic approaches such as targeting the HO-1–SIRT1–PGC-1α axis to prevent cardiomyopathy and heart failure, which is a major source of morbidity and mortality in diabetic patients. Here, HMOX1 is linked to heart failure.